本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Unicycive Therapeutics, Inc.

5.29
-0.0200-0.38%
盤後5.19-0.0997-1.88%19:30 EDT
成交量:111.67萬
成交額:591.15萬
市值:1.47億
市盈率:-3.39
高:5.40
開:5.34
低:5.22
收:5.31
52周最高:8.74
52周最低:3.71
股本:2,785.53萬
流通股本:2,722.58萬
量比:1.30
換手率:4.10%
股息:- -
股息率:- -
每股收益(TTM):-1.5585
每股收益(LYR):-1.6715
淨資產收益率:-101.07%
總資產收益率:-40.59%
市淨率:2.77
市盈率(LYR):-3.16

資料載入中...

2022/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/29

重要事件披露

8-K - Current report
2021/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/14

SEC問詢函

CORRESP [Cover] - Correspondence